Funding round
Enveda Seed
Enveda, which works in drug discovery and development in Boulder, raised $4.9M in a Seed round announced on 27 Dec 2020, led by True Ventures. 3 firms took part. It is Enveda's first venture round on record.
$4.9M
Amount raised
Not disclosed
Post-money valuation
3
Investors
1 lead
Valuation
What this round says about the price
Enveda did not disclose a valuation in this round. It is Enveda's first venture round on record, 1 year after it was founded in 2019. It is under 1% of the $715M Enveda has raised in the venture rounds on record. Enveda raised again 6 months later: a Series A round of $51M in Jun 2021. Its next priced round, a Series E in Sep 2026, valued it at $2.00B.
Enveda's funding rounds
Enveda has 6 venture rounds on record. This one is highlighted.
- Seed this round 27 Dec 2020, led by True Ventures $4.9M
- Series A 22 Jun 2021, led by Lux Capital $51M
- Series B 21 Dec 2022, led by Dimension $68M
- Series C 21 Nov 2024, led by Kinnevik and FPV Ventures $130M
- Series D 4 Sep 2025, led by Premji Invest $150M
- Series E 23 Sep 2026, led by Catalio Capital Management $311M$2.00B post-money
Investors
Who put money in
True Ventures led the round with 2 other firms.
Lead investor
- backs 158 venture-backed companies new investor
Also in the round
- backs 24 venture-backed companies new investor
- backs 120 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
114 Seed rounds in Biotechnology within a year either side disclosed an amount; the median was $4.0M, and this round was 1.2 times the median. The closest in time, other companies' Seed rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 1 Dec 2020 | $6.0M | not disclosed | not named |
| Biotechnology | 7 Dec 2020 | $5.4M | not disclosed | Rev1 Ventures |
| Biotechnology | 14 Dec 2020 | $3.2M | not disclosed | XAnge |
| Biotechnology | 27 Jan 2021 | $13M | not disclosed | Polaris Partners and Arkin Capital |
| Biotechnology | 19 Jan 2021 | $6.2M | not disclosed | AMP Squared Capital Partners |
| Biotechnology | 16 Nov 2020 | $5.9M | not disclosed | not named |
| Biotechnology | 3 Nov 2020 | $2.5M | not disclosed | not named |
| Peptone Biotechnology | 8 Jan 2021 | $2.5M | not disclosed | Hoxton Ventures |
Sources
Where this comes from
Reported by 1 source.
Questions
Frequently asked
How much did Enveda raise in its Seed round?
Enveda raised $4.9M in its Seed round, announced in Dec 2020.
Who led Enveda's Seed round?
True Ventures led it, with Wireframe Ventures and Village Global.
What was Enveda's valuation at the Seed round?
It was not disclosed.
How does it compare with other Seed rounds in Biotechnology?
114 Seed rounds in Biotechnology within a year either side disclosed an amount; the median was $4.0M, and this round was 1.2 times the median.
Did Enveda raise again after this round?
Yes: a Series A round in Jun 2021 of $51M.